For the first time, researchers at the University of Washington will test whether two treatments are better than one for patients with fibromyalgia.
Fibromyalgia (FM) is a common and disabling disorder. Currently, no single treatment has been found to be totally effective for all who have FM. With a $5.5 million grant from the National Institutes of Health, the University of Washington’s Fibromyalgia Research Program is currently conducting a study to compare the benefits of combining pharmacological and behavioral health treatments for FM. The need for a study like this stems from the lack of therapies that provide more than modest relief for the estimated 3 to 6 million Americans, mostly women, with the often debilitating disorder.
This is a randomized control study that involves a combination of a drug treatment, behavioral health treatment, and placebo controls. Participants will be randomly assigned to a treatment (like flipping a coin). Some participants will receive a medication approved by the Food and Drug Administration for treatment of moderate to moderately severe pain called Tramadol HC1 IR. Others will receive an inactive pill, called a placebo. There will also be 2 different types of behavioral health treatments, Cognitive-Behavioral Therapy (CBT) and Health Education (HE,) both of which have been recommended for the treatment of patients with FM by the American Pain Society.
If you or someone you know may be interested in participating in this study, please contact the Fibromyalgia Research Program at (206)221-1737 or firstname.lastname@example.org (we cannot guarantee the confidentiality of any information sent via e-mail).
UW studies combination treatment for people with Fibromyalgia(1 post)
For the first time, researchers at the University of Washington will test whether two treatments are better than one for patients with fibromyalgia.Posted 1 year ago #
You must log in to post.